MERS-CoV diagnosis: An update
Identifieur interne : 000E39 ( Pmc/Corpus ); précédent : 000E38; suivant : 000E40MERS-CoV diagnosis: An update
Auteurs : Sameera Al Johani ; Ali H. HajeerSource :
- Journal of Infection and Public Health [ 1876-0341 ] ; 2016.
Abstract
Diagnosis of MERS-Cov still a major concern in most of daignostic laboratories. To date the Real-time Polymerase Chain reaction (RT-PCR) is the mainstay for diagnosis of MERS-CoV. RT-PCR has limitations, including a long turnaround time and lack of common measurements and correlations with Viral Load (VL). It is recommended to screen for MERS-CoV using RT-PCR of the upstream of envelope gene (upE) followed by confirmation of the presence of one of the following genes; open reading frame 1A, 1B genes or nucleocapsid (N) gene. Scientists are looking to implement viral sequencing on all negative samples by RT-PCR and they beleive that can be exposed to another level of testing using sequencing of the RNA-dependent RNA polymerase (RdRp) gene or N gene and in this case a positive result is diagnostic. It is also very important to maintain a contineous and random sequencing for MERS-Cov samples to be able to pick early viral mutations. Serological assays still not widely or routinely performed, and a lot of studies looking to implement such method in routine patient's testings.
Url:
DOI: 10.1016/j.jiph.2016.04.005
PubMed: 27106390
PubMed Central: 7102781
Links to Exploration step
PMC:7102781Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">MERS-CoV diagnosis: An update</title><author><name sortKey="Al Johani, Sameera" sort="Al Johani, Sameera" uniqKey="Al Johani S" first="Sameera" last="Al Johani">Sameera Al Johani</name></author><author><name sortKey="Hajeer, Ali H" sort="Hajeer, Ali H" uniqKey="Hajeer A" first="Ali H." last="Hajeer">Ali H. Hajeer</name></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">27106390</idno><idno type="pmc">7102781</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102781</idno><idno type="RBID">PMC:7102781</idno><idno type="doi">10.1016/j.jiph.2016.04.005</idno><date when="2016">2016</date><idno type="wicri:Area/Pmc/Corpus">000E39</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000E39</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">MERS-CoV diagnosis: An update</title><author><name sortKey="Al Johani, Sameera" sort="Al Johani, Sameera" uniqKey="Al Johani S" first="Sameera" last="Al Johani">Sameera Al Johani</name></author><author><name sortKey="Hajeer, Ali H" sort="Hajeer, Ali H" uniqKey="Hajeer A" first="Ali H." last="Hajeer">Ali H. Hajeer</name></author></analytic><series><title level="j">Journal of Infection and Public Health</title><idno type="ISSN">1876-0341</idno><idno type="eISSN">1876-035X</idno><imprint><date when="2016">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><title>Summary</title><p>Diagnosis of MERS-Cov still a major concern in most of daignostic laboratories. To date the Real-time Polymerase Chain reaction (RT-PCR) is the mainstay for diagnosis of MERS-CoV. RT-PCR has limitations, including a long turnaround time and lack of common measurements and correlations with Viral Load (VL). It is recommended to screen for MERS-CoV using RT-PCR of the upstream of envelope gene (upE) followed by confirmation of the presence of one of the following genes; open reading frame 1A, 1B genes or nucleocapsid (N) gene. Scientists are looking to implement viral sequencing on all negative samples by RT-PCR and they beleive that can be exposed to another level of testing using sequencing of the RNA-dependent RNA polymerase (RdRp) gene or N gene and in this case a positive result is diagnostic. It is also very important to maintain a contineous and random sequencing for MERS-Cov samples to be able to pick early viral mutations. Serological assays still not widely or routinely performed, and a lot of studies looking to implement such method in routine patient's testings.</p></div></front><back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Memish, Z A" uniqKey="Memish Z">Z.A. Memish</name></author><author><name sortKey="Al Tawfiq, J A" uniqKey="Al Tawfiq J">J.A. Al-Tawfiq</name></author><author><name sortKey="Makhdoom, H Q" uniqKey="Makhdoom H">H.Q. Makhdoom</name></author><author><name sortKey="Assiri, A" uniqKey="Assiri A">A. Assiri</name></author><author><name sortKey="Alhakeem, R F" uniqKey="Alhakeem R">R.F. Alhakeem</name></author><author><name sortKey="Albarrak, A" uniqKey="Albarrak A">A. Albarrak</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Guery, B" uniqKey="Guery B">B. Guery</name></author><author><name sortKey="Poissy, J" uniqKey="Poissy J">J. Poissy</name></author><author><name sortKey="El Mansouf, L" uniqKey="El Mansouf L">L. el Mansouf</name></author><author><name sortKey="Sejourne, C" uniqKey="Sejourne C">C. Sejourne</name></author><author><name sortKey="Ettahar, N" uniqKey="Ettahar N">N. Ettahar</name></author><author><name sortKey="Lemaire, X" uniqKey="Lemaire X">X. Lemaire</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ulmer, A J" uniqKey="Ulmer A">A.J. Ulmer</name></author><author><name sortKey="Mattern, T" uniqKey="Mattern T">T. Mattern</name></author><author><name sortKey="Flad, H D" uniqKey="Flad H">H.D. Flad</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Feikin, D R" uniqKey="Feikin D">D.R. Feikin</name></author><author><name sortKey="Alraddadi, B" uniqKey="Alraddadi B">B. Alraddadi</name></author><author><name sortKey="Qutub, M" uniqKey="Qutub M">M. Qutub</name></author><author><name sortKey="Shabouni, O" uniqKey="Shabouni O">O. Shabouni</name></author><author><name sortKey="Curns, A" uniqKey="Curns A">A. Curns</name></author><author><name sortKey="Oboho, I K" uniqKey="Oboho I">I.K. Oboho</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Corman, V M" uniqKey="Corman V">V.M. Corman</name></author><author><name sortKey="Olschlager, S" uniqKey="Olschlager S">S. Olschlager</name></author><author><name sortKey="Wendtner, C M" uniqKey="Wendtner C">C.M. Wendtner</name></author><author><name sortKey="Drexler, J F" uniqKey="Drexler J">J.F. Drexler</name></author><author><name sortKey="Hess, M" uniqKey="Hess M">M. Hess</name></author><author><name sortKey="Drosten, C" uniqKey="Drosten C">C. Drosten</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Seong, M W" uniqKey="Seong M">M.W. Seong</name></author><author><name sortKey="Lee, S J" uniqKey="Lee S">S.J. Lee</name></author><author><name sortKey="Cho, S I" uniqKey="Cho S">S.I. Cho</name></author><author><name sortKey="Ko, K" uniqKey="Ko K">K. Ko</name></author><author><name sortKey="Kim, M N" uniqKey="Kim M">M.N. Kim</name></author><author><name sortKey="Sung, H" uniqKey="Sung H">H. Sung</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Pas, S D" uniqKey="Pas S">S.D. Pas</name></author><author><name sortKey="Patel, P" uniqKey="Patel P">P. Patel</name></author><author><name sortKey="Reusken, C" uniqKey="Reusken C">C. Reusken</name></author><author><name sortKey="Domingo, C" uniqKey="Domingo C">C. Domingo</name></author><author><name sortKey="Corman, V M" uniqKey="Corman V">V.M. Corman</name></author><author><name sortKey="Drosten, C" uniqKey="Drosten C">C. Drosten</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Zaki, A M" uniqKey="Zaki A">A.M. Zaki</name></author><author><name sortKey="Van Boheemen, S" uniqKey="Van Boheemen S">S. van Boheemen</name></author><author><name sortKey="Bestebroer, T M" uniqKey="Bestebroer T">T.M. Bestebroer</name></author><author><name sortKey="Osterhaus, A D" uniqKey="Osterhaus A">A.D. Osterhaus</name></author><author><name sortKey="Fouchier, R A" uniqKey="Fouchier R">R.A. Fouchier</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Seong, M W" uniqKey="Seong M">M.W. Seong</name></author><author><name sortKey="Kim, S Y" uniqKey="Kim S">S.Y. Kim</name></author><author><name sortKey="Corman, V M" uniqKey="Corman V">V.M. Corman</name></author><author><name sortKey="Kim, T S" uniqKey="Kim T">T.S. Kim</name></author><author><name sortKey="Cho, S I" uniqKey="Cho S">S.I. Cho</name></author><author><name sortKey="Kim, M J" uniqKey="Kim M">M.J. Kim</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Borucki, M K" uniqKey="Borucki M">M.K. Borucki</name></author><author><name sortKey="Lao, V" uniqKey="Lao V">V. Lao</name></author><author><name sortKey="Hwang, M" uniqKey="Hwang M">M. Hwang</name></author><author><name sortKey="Gardner, S" uniqKey="Gardner S">S. Gardner</name></author><author><name sortKey="Adney, D" uniqKey="Adney D">D. Adney</name></author><author><name sortKey="Munster, V" uniqKey="Munster V">V. Munster</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Assiri, A" uniqKey="Assiri A">A. Assiri</name></author><author><name sortKey="Abedi, G R" uniqKey="Abedi G">G.R. Abedi</name></author><author><name sortKey="Saeed, A A" uniqKey="Saeed A">A.A. Saeed</name></author><author><name sortKey="Abdalla, M A" uniqKey="Abdalla M">M.A. Abdalla</name></author><author><name sortKey="Al Masry, M" uniqKey="Al Masry M">M. Al-Masry</name></author><author><name sortKey="Choudhry, A J" uniqKey="Choudhry A">A.J. Choudhry</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kim, Y" uniqKey="Kim Y">Y. Kim</name></author><author><name sortKey="Cheon, S" uniqKey="Cheon S">S. Cheon</name></author><author><name sortKey="Min, C K" uniqKey="Min C">C.K. Min</name></author><author><name sortKey="Sohn, K M" uniqKey="Sohn K">K.M. Sohn</name></author><author><name sortKey="Kang, Y J" uniqKey="Kang Y">Y.J. Kang</name></author><author><name sortKey="Cha, Y J" uniqKey="Cha Y">Y.J. Cha</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Park, W B" uniqKey="Park W">W.B. Park</name></author><author><name sortKey="Perera, R A" uniqKey="Perera R">R.A. Perera</name></author><author><name sortKey="Choe, P G" uniqKey="Choe P">P.G. Choe</name></author><author><name sortKey="Lau, E H" uniqKey="Lau E">E.H. Lau</name></author><author><name sortKey="Choi, S J" uniqKey="Choi S">S.J. Choi</name></author><author><name sortKey="Chun, J Y" uniqKey="Chun J">J.Y. Chun</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chen, Y" uniqKey="Chen Y">Y. Chen</name></author><author><name sortKey="Chan, K H" uniqKey="Chan K">K.H. Chan</name></author><author><name sortKey="Kang, Y" uniqKey="Kang Y">Y. Kang</name></author><author><name sortKey="Chen, H" uniqKey="Chen H">H. Chen</name></author><author><name sortKey="Luk, H" uniqKey="Luk H">H. Luk</name></author><author><name sortKey="Poon, R W" uniqKey="Poon R">R.W. Poon</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Meyer, B" uniqKey="Meyer B">B. Meyer</name></author><author><name sortKey="Drosten, C" uniqKey="Drosten C">C. Drosten</name></author><author><name sortKey="Muller, M A" uniqKey="Muller M">M.A. Muller</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Perera, R A" uniqKey="Perera R">R.A. Perera</name></author><author><name sortKey="Wang, P" uniqKey="Wang P">P. Wang</name></author><author><name sortKey="Gomaa, M R" uniqKey="Gomaa M">M.R. Gomaa</name></author><author><name sortKey="El Shesheny, R" uniqKey="El Shesheny R">R. El-Shesheny</name></author><author><name sortKey="Kandeil, A" uniqKey="Kandeil A">A. Kandeil</name></author><author><name sortKey="Bagato, O" uniqKey="Bagato O">O. Bagato</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Buchholz, U" uniqKey="Buchholz U">U. Buchholz</name></author><author><name sortKey="Muller, M A" uniqKey="Muller M">M.A. Muller</name></author><author><name sortKey="Nitsche, A" uniqKey="Nitsche A">A. Nitsche</name></author><author><name sortKey="Sanewski, A" uniqKey="Sanewski A">A. Sanewski</name></author><author><name sortKey="Wevering, N" uniqKey="Wevering N">N. Wevering</name></author><author><name sortKey="Bauer Balci, T" uniqKey="Bauer Balci T">T. Bauer-Balci</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Corman, V M" uniqKey="Corman V">V.M. Corman</name></author><author><name sortKey="Muller, M A" uniqKey="Muller M">M.A. Muller</name></author><author><name sortKey="Costabel, U" uniqKey="Costabel U">U. Costabel</name></author><author><name sortKey="Timm, J" uniqKey="Timm J">J. Timm</name></author><author><name sortKey="Binger, T" uniqKey="Binger T">T. Binger</name></author><author><name sortKey="Meyer, B" uniqKey="Meyer B">B. Meyer</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Muller, M A" uniqKey="Muller M">M.A. Muller</name></author><author><name sortKey="Meyer, B" uniqKey="Meyer B">B. Meyer</name></author><author><name sortKey="Corman, V M" uniqKey="Corman V">V.M. Corman</name></author><author><name sortKey="Al Masri, M" uniqKey="Al Masri M">M. Al-Masri</name></author><author><name sortKey="Turkestani, A" uniqKey="Turkestani A">A. Turkestani</name></author><author><name sortKey="Ritz, D" uniqKey="Ritz D">D. Ritz</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Wang, Y D" uniqKey="Wang Y">Y.D. Wang</name></author><author><name sortKey="Li, Y" uniqKey="Li Y">Y. Li</name></author><author><name sortKey="Xu, G B" uniqKey="Xu G">G.B. Xu</name></author><author><name sortKey="Dong, X Y" uniqKey="Dong X">X.Y. Dong</name></author><author><name sortKey="Yang, X A" uniqKey="Yang X">X.A. Yang</name></author><author><name sortKey="Feng, Z R" uniqKey="Feng Z">Z.R. Feng</name></author></analytic></biblStruct></listBibl></div1></back></TEI><pmc article-type="research-article"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">J Infect Public Health</journal-id><journal-id journal-id-type="iso-abbrev">J Infect Public Health</journal-id><journal-title-group><journal-title>Journal of Infection and Public Health</journal-title></journal-title-group><issn pub-type="ppub">1876-0341</issn><issn pub-type="epub">1876-035X</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27106390</article-id><article-id pub-id-type="pmc">7102781</article-id><article-id pub-id-type="publisher-id">S1876-0341(16)30022-3</article-id><article-id pub-id-type="doi">10.1016/j.jiph.2016.04.005</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>MERS-CoV diagnosis: An update</article-title></title-group><contrib-group><contrib contrib-type="author" id="aut0005"><name><surname>Al Johani</surname><given-names>Sameera</given-names></name><email>johanis@ngha.med.sa</email><xref rid="cor0005" ref-type="corresp">⁎</xref></contrib><contrib contrib-type="author" id="aut0010"><name><surname>Hajeer</surname><given-names>Ali H.</given-names></name></contrib></contrib-group><aff id="aff0005">Department of Pathology and Laboratory Medicine, King Saud University for Health Sciences, Riyadh, Saudi Arabia</aff><author-notes><corresp id="cor0005"><label>⁎</label>Corresponding author at: Division of Microbiology, Pathology and Laboratory Medicine, Mail Code 1122, King Abdulaziz Medical City, P.O. Box 22490, Riyadh 11426, Saudi Arabia. Tel.: +966 558891414. <email>johanis@ngha.med.sa</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>20</day><month>4</month><year>2016</year></pub-date><pmc-comment> PMC Release delay is 0 months and 0 days and was based on .</pmc-comment>
<pub-date pub-type="ppub"><season>May-Jun</season><year>2016</year></pub-date><pub-date pub-type="epub"><day>20</day><month>4</month><year>2016</year></pub-date><volume>9</volume><issue>3</issue><fpage>216</fpage><lpage>219</lpage><history><date date-type="received"><day>4</day><month>4</month><year>2016</year></date><date date-type="accepted"><day>5</day><month>4</month><year>2016</year></date></history><permissions><copyright-statement>© 2016 King Saud Bin Abdulaziz University for Health Sciences. Production and hosting by Elsevier Limited.</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>King Saud Bin Abdulaziz University for Health Sciences</copyright-holder><license><license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p></license></permissions><abstract id="abs1005"><title>Summary</title><p>Diagnosis of MERS-Cov still a major concern in most of daignostic laboratories. To date the Real-time Polymerase Chain reaction (RT-PCR) is the mainstay for diagnosis of MERS-CoV. RT-PCR has limitations, including a long turnaround time and lack of common measurements and correlations with Viral Load (VL). It is recommended to screen for MERS-CoV using RT-PCR of the upstream of envelope gene (upE) followed by confirmation of the presence of one of the following genes; open reading frame 1A, 1B genes or nucleocapsid (N) gene. Scientists are looking to implement viral sequencing on all negative samples by RT-PCR and they beleive that can be exposed to another level of testing using sequencing of the RNA-dependent RNA polymerase (RdRp) gene or N gene and in this case a positive result is diagnostic. It is also very important to maintain a contineous and random sequencing for MERS-Cov samples to be able to pick early viral mutations. Serological assays still not widely or routinely performed, and a lot of studies looking to implement such method in routine patient's testings.</p></abstract><kwd-group id="kwd0005"><title>Keywords</title><kwd>MERS-COV</kwd><kwd>RT-PCR</kwd><kwd>Serology</kwd><kwd>Sequencing</kwd></kwd-group></article-meta></front><body><p id="par0005">Three years have passed since the discovery of the newly emerging coronavirus namely Middle East Respiratory Syndrome Coronavirus (MERS-Cov) and many questions are still unanswered. We will summarize the latest diagnostic testing for confirmation of a case with MERS-CoV infection raising some questions that are still unanswered.</p><sec id="sec0005"><title>Sampling</title><p id="par0010">Detecting the virus in respiratory tract samples remains the gold standard in diagnosing MERS-CoV infection. Several samples can be obtained from the respiratory system that can be used for diagnosing MERS-CoV infection. These include tracheal aspirates, nasopharyngeal swabs, bronchoalveolar lavage and sputum. Tracheal aspirates and bronchoalveolar lavage samples (lower respiratory samples) yielded significantly higher viral copies than nasopharyngeal and sputum samples <xref rid="bib0110" ref-type="bibr">[1]</xref>. Analyzing whole blood and plasma also yielded positive viral genome <xref rid="bib0115" ref-type="bibr">[2]</xref>. The kinetics of viral presence in blood is not well understood. The observation of lymphopenia in severe cases and the presence of the virus receptor on naïve and memory T lymphocytes <xref rid="bib0120" ref-type="bibr">[3]</xref> warrant the study of viral replication inside T lymphocytes.</p></sec><sec id="sec0010"><title>PCR</title><p id="par0015">To date the Real-time Polymerase Chain reaction (RT-PCR) is the mainstay for diagnosis of MERS-CoV. RT-PCR has limitations, including a long turnaround time (chiefly due to transportation of virus and test preparation), and lack of common measurements and correlations with Viral Load (VL). Most laboratories are determining only cycle threshold (<italic>C</italic><sub>t</sub>) values (which are inversely related to virus load) as a predictor for VL, disease progression and as a cut off marker in order to diagnose cases. Yet, few studies have evaluated whether cycle threshold (<italic>C</italic><sub><italic>t</italic></sub>) values are associated with clinical severity <xref rid="bib0125" ref-type="bibr">[4]</xref>.</p><p id="par0020">It is recommended to screen for MERS-CoV using RT-PCR of the upstream of envelope gene (upE) followed by confirmation of the presence of one of the following genes; open reading frame 1A, 1B genes or nucleocapsid (N) gene <xref rid="bib0130" ref-type="bibr">[5]</xref>. Negative samples by RT-PCR can be exposed to another level of testing using sequencing of the RNA-dependent RNA polymerase (RdRp) gene or N gene <xref rid="bib0130" ref-type="bibr">[5]</xref> and in this case a positive result is diagnostic. Commercially available kits utilizing this algorithm were tested and found to be highly sensitive and specific <xref rid="bib0135" ref-type="bibr">[6]</xref>.</p><p id="par0025">Quality of reported results should be maintained at all times. Part of the quality programs available is the external proficiency testing. This method was applied locally during the Korean outbreak <xref rid="bib0140" ref-type="bibr">[7]</xref> and later at a wider level <xref rid="bib0145" ref-type="bibr">[8]</xref>.</p></sec><sec id="sec0015"><title>Sequencing and molecular data</title><p id="par0030">In an attempt to uncover the nature of the first isolate of the virus, Zaki et al. <xref rid="bib0150" ref-type="bibr">[9]</xref> used random primers to sequence the virus RNA. The sequence revealed several open reading frames common to betacoronaviruses, such as 1ab, which encodes many enzymatic products, the spike (S) protein, the small-envelope (E) protein, the matrix (M) protein, and the nucleocapsid (N) protein.</p><p id="par0035">Seong et al. <xref rid="bib0155" ref-type="bibr">[10]</xref> also sequenced MERS-CoV viral genomes from four Korean patients during the May–July 2015 outbreak. There was no evidence of substantial evolutionary change in the virus compared to Middle Eastern sequences. Borucki et al. <xref rid="bib0160" ref-type="bibr">[11]</xref> used deep sequencing on nasal samples of three camels that were infected with MERS-CoV and found only 5 mutations in the consensus sequences. Yet, any mutations could potentially influence the virus phenotype and impact the detection of the virus by molecular assays.</p><p id="par0040">Assiri et al. <xref rid="bib0165" ref-type="bibr">[12]</xref> sequenced MERS-CoV spike gene in an outbreak in Taif. Phylogenetic analysis of their samples revealed a cluster located within the Hafr-Al-Batin clade and were closely related to viruses isolated from Riyadh during 2013 and 2014 outbreaks. They also identified five unique nucleotide substitutions in the spike protein <xref rid="bib0165" ref-type="bibr">[12]</xref>. Whereas, Kim et al. <xref rid="bib0170" ref-type="bibr">[13]</xref> found mutations in the receptor binding domain of the S protein in 12 out of 13 MERS-CoV isolates from Korea resulting in reduced affinity to the human receptor CD26.</p><p id="par0045">These data suggest that sequencing of MERS-CoV is likely warranted for any new and subsequent outbreaks. Changes that may affect the virulence of the virus. In addition, it will be important to observe the location of new mutations in the virus genes and in order to attempt to predict effects on primer and probe binding sites, which may influence diagnostic ability of the currently available commercial kits.</p></sec><sec id="sec0020"><title>Serology testing</title><p id="par0050">As with other acute viruses, detection of antibodies and even antigens might lag sometime after the detection of viral genome by molecular methods. The kinetics of antigen production in the nasopharyngeal samples has not been studied so far. However, antibodies to the virus generally appear after 10 days of the illness onset. In severely ill patients requiring mechanical ventilation, antibodies were delayed further <xref rid="bib0175" ref-type="bibr">[14]</xref>.</p><p id="par0055">An ELISA capture assay to detect NP antigens of the MERS-CoV virus in nasopharyngeal samples was developed recently <xref rid="bib0180" ref-type="bibr">[15]</xref>. The assay was highly sensitive (detection of the MERS-CoV-NP of less than 1 ng/mL) and specific (specificity of 100%) for MERS-CoV and has the potential to be used in animals a well. Song et al. developed a rapid immunochromatographic assay for the detection of MERS-CoV nucleocapsid protein from camel nasal swabs with 93.9% sensitivity and 100% specificity compared to RT-rtPCR. The assay is very promising and worth replication in both camel and humans. As yet, antigen detection assays are not widely available; yet this type of assays will ideally be valuable in ruling infection in, and out.</p><p id="par0060">MERS-CoV is very similar to SARS, both are betacoronaviruses; and in both cases the S and N proteins are very immunogenic and good candidates for developing an immune assay for the detection of virus specific antibodies <xref rid="bib0185" ref-type="bibr">[16]</xref>. Several assays have been developed to detect antibodies to MERS-CoV; including neutralization assays, ELISA and IFA.</p><p id="par0065">Perera et al. <xref rid="bib0190" ref-type="bibr">[17]</xref> developed a microneutralization assay to detect specific anti-MERS-Cov antibodies. They used serial dilution of serum which was incubated with Vero cells/MERS-CoV virus. After three days at 37 °C, they scored the antibody titers based on the virus CPE. In addition, they developed a MERS-CoV spike pseudoparticle neutralization assay <xref rid="bib0190" ref-type="bibr">[17]</xref>. They used HIV/MERS spike pseudoparticles to infect Vero E6 cells, after 2 days infected cells were lysed and the antibody that gave 90% luciferase reduction was assigned as ppNA antibody titer. Compared to virus neutralization assay, the pseudoparticle neutralization assay does not require BSL3 containment.</p><p id="par0070">Indirect fluorescent antibody assay for the detection of antibodies to MERS-CoV was carried out using whole virus in Vero cells <xref rid="bib0195" ref-type="bibr">[18]</xref>, <xref rid="bib0200" ref-type="bibr">[19]</xref> or transfected Vero cells with spike or nucleocapsid proteins of MERS-CoV <xref rid="bib0195" ref-type="bibr">[18]</xref>. ELISA utilizing S1 protein is also available and been used for investigating epidemiology of the exposure to the virus <xref rid="bib0205" ref-type="bibr">[20]</xref>. So far, there are no studies comparing ELISA for the detection of anti-MERS-CoV antibodies with either IFA or neutralization assays.</p><p id="par0075">Detection of anti-MERS-CoV antibodies using the different assays described above still requires confirmation by the neutralization assays. Other techniques are needed to support confirmation of the antibody specificity, as neutralization assay is not widely used. Western blotting has been used in SARS <xref rid="bib0210" ref-type="bibr">[21]</xref> and other viruses to confirm antibody specificity. There is a need for Western blotting assay in case of MERS-CoV to confirm antibody specificity. This can be in the form of genetically engineered specific MERS-CoV antigens blotted on membranes.</p><p id="par0080">In summary, molecular techniques are the first line of assays to be used for confirmation of MERS-CoV infection. Tracheal aspirates and bronchoalveolar lavage samples (lower respiratory samples) are recommended for detecting the virus by RT-PCR or sequencing. Serology is valuable confirming cases suspected for MERS-CoV but the virus is not detected in respiratory samples.</p></sec><sec id="sec0025"><title>Funding</title><p id="par0085">No funding sources.</p></sec><sec id="sec0030"><title>Competing interests</title><p id="par0090">None declared.</p></sec><sec id="sec0035"><title>Ethical approval</title><p id="par0095">Not required.</p></sec></body><back><ref-list id="bibl0005"><title>References</title><ref id="bib0110"><label>1</label><element-citation publication-type="journal" id="sbref0110"><person-group person-group-type="author"><name><surname>Memish</surname><given-names>Z.A.</given-names></name><name><surname>Al-Tawfiq</surname><given-names>J.A.</given-names></name><name><surname>Makhdoom</surname><given-names>H.Q.</given-names></name><name><surname>Assiri</surname><given-names>A.</given-names></name><name><surname>Alhakeem</surname><given-names>R.F.</given-names></name><name><surname>Albarrak</surname><given-names>A.</given-names></name></person-group><article-title>Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome</article-title><source>J Infect Dis</source><volume>210</volume><issue>10</issue><year>2014</year><fpage>1590</fpage><lpage>1594</lpage><pub-id pub-id-type="pmid">24837403</pub-id></element-citation></ref><ref id="bib0115"><label>2</label><element-citation publication-type="journal" id="sbref0115"><person-group person-group-type="author"><name><surname>Guery</surname><given-names>B.</given-names></name><name><surname>Poissy</surname><given-names>J.</given-names></name><name><surname>el Mansouf</surname><given-names>L.</given-names></name><name><surname>Sejourne</surname><given-names>C.</given-names></name><name><surname>Ettahar</surname><given-names>N.</given-names></name><name><surname>Lemaire</surname><given-names>X.</given-names></name></person-group><article-title>Clinical features and viral diagnosis of two cases of infection with Middle East respiratory syndrome coronavirus: a report of nosocomial transmission</article-title><source>Lancet</source><volume>381</volume><issue>9885</issue><year>2013</year><fpage>2265</fpage><lpage>2272</lpage><pub-id pub-id-type="pmid">23727167</pub-id></element-citation></ref><ref id="bib0120"><label>3</label><element-citation publication-type="journal" id="sbref0120"><person-group person-group-type="author"><name><surname>Ulmer</surname><given-names>A.J.</given-names></name><name><surname>Mattern</surname><given-names>T.</given-names></name><name><surname>Flad</surname><given-names>H.D.</given-names></name></person-group><article-title>Expression of CD26 (dipeptidyl peptidase IV) on memory and naive T lymphocytes</article-title><source>Scand J Immunol</source><volume>35</volume><issue>5</issue><year>1992</year><fpage>551</fpage><lpage>559</lpage><pub-id pub-id-type="pmid">1374571</pub-id></element-citation></ref><ref id="bib0125"><label>4</label><element-citation publication-type="journal" id="sbref0125"><person-group person-group-type="author"><name><surname>Feikin</surname><given-names>D.R.</given-names></name><name><surname>Alraddadi</surname><given-names>B.</given-names></name><name><surname>Qutub</surname><given-names>M.</given-names></name><name><surname>Shabouni</surname><given-names>O.</given-names></name><name><surname>Curns</surname><given-names>A.</given-names></name><name><surname>Oboho</surname><given-names>I.K.</given-names></name></person-group><article-title>Association of higher MERS-CoV virus load with severe disease and death, Saudi Arabia, 2014</article-title><source>Emerg Infect Dis</source><volume>21</volume><issue>11</issue><year>2015</year><fpage>2029</fpage><lpage>2035</lpage><pub-id pub-id-type="pmid">26488195</pub-id></element-citation></ref><ref id="bib0130"><label>5</label><mixed-citation publication-type="other" id="oref0025">Laboratory testing for Middle East respiratory syndrome coronavirus (MERS-CoV). <ext-link ext-link-type="uri" xlink:href="http://apps.who.int/iris/bitstream/10665/176982/1/WHO_MERS_LAB_15.1_eng.pdf?ua=1" id="intr0005">http://apps.who.int/iris/bitstream/10665/176982/1/WHO_MERS_LAB_15.1_eng.pdf?ua=1</ext-link>.</mixed-citation></ref><ref id="bib0135"><label>6</label><element-citation publication-type="journal" id="sbref0135"><person-group person-group-type="author"><name><surname>Corman</surname><given-names>V.M.</given-names></name><name><surname>Olschlager</surname><given-names>S.</given-names></name><name><surname>Wendtner</surname><given-names>C.M.</given-names></name><name><surname>Drexler</surname><given-names>J.F.</given-names></name><name><surname>Hess</surname><given-names>M.</given-names></name><name><surname>Drosten</surname><given-names>C.</given-names></name></person-group><article-title>Performance and clinical validation of the RealStar MERS-CoV Kit for detection of Middle East respiratory syndrome coronavirus RNA</article-title><source>J Clin Virol</source><volume>60</volume><issue>2</issue><year>2014</year><fpage>168</fpage><lpage>171</lpage><pub-id pub-id-type="pmid">24726679</pub-id></element-citation></ref><ref id="bib0140"><label>7</label><element-citation publication-type="journal" id="sbref0140"><person-group person-group-type="author"><name><surname>Seong</surname><given-names>M.W.</given-names></name><name><surname>Lee</surname><given-names>S.J.</given-names></name><name><surname>Cho</surname><given-names>S.I.</given-names></name><name><surname>Ko</surname><given-names>K.</given-names></name><name><surname>Kim</surname><given-names>M.N.</given-names></name><name><surname>Sung</surname><given-names>H.</given-names></name></person-group><article-title>External Quality Assessment of MERS-CoV molecular diagnostics during the 2015 Korean outbreak</article-title><source>Ann Lab Med</source><volume>36</volume><issue>3</issue><year>2016</year><fpage>230</fpage><lpage>234</lpage><pub-id pub-id-type="pmid">26915611</pub-id></element-citation></ref><ref id="bib0145"><label>8</label><element-citation publication-type="journal" id="sbref0145"><person-group person-group-type="author"><name><surname>Pas</surname><given-names>S.D.</given-names></name><name><surname>Patel</surname><given-names>P.</given-names></name><name><surname>Reusken</surname><given-names>C.</given-names></name><name><surname>Domingo</surname><given-names>C.</given-names></name><name><surname>Corman</surname><given-names>V.M.</given-names></name><name><surname>Drosten</surname><given-names>C.</given-names></name></person-group><article-title>First international external quality assessment of molecular diagnostics for Mers-CoV</article-title><source>J Clin Virol</source><volume>69</volume><year>2015</year><fpage>81</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">26209385</pub-id></element-citation></ref><ref id="bib0150"><label>9</label><element-citation publication-type="journal" id="sbref0150"><person-group person-group-type="author"><name><surname>Zaki</surname><given-names>A.M.</given-names></name><name><surname>van Boheemen</surname><given-names>S.</given-names></name><name><surname>Bestebroer</surname><given-names>T.M.</given-names></name><name><surname>Osterhaus</surname><given-names>A.D.</given-names></name><name><surname>Fouchier</surname><given-names>R.A.</given-names></name></person-group><article-title>Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia</article-title><source>N Engl J Med</source><volume>367</volume><issue>19</issue><year>2012</year><fpage>1814</fpage><lpage>1820</lpage><pub-id pub-id-type="pmid">23075143</pub-id></element-citation></ref><ref id="bib0155"><label>10</label><element-citation publication-type="journal" id="sbref0155"><person-group person-group-type="author"><name><surname>Seong</surname><given-names>M.W.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name><name><surname>Corman</surname><given-names>V.M.</given-names></name><name><surname>Kim</surname><given-names>T.S.</given-names></name><name><surname>Cho</surname><given-names>S.I.</given-names></name><name><surname>Kim</surname><given-names>M.J.</given-names></name></person-group><article-title>Microevolution of outbreak-associated Middle East respiratory syndrome coronavirus, South Korea, 2015</article-title><source>Emerg Infect Dis</source><volume>22</volume><issue>2</issue><year>2016</year></element-citation></ref><ref id="bib0160"><label>11</label><element-citation publication-type="journal" id="sbref0160"><person-group person-group-type="author"><name><surname>Borucki</surname><given-names>M.K.</given-names></name><name><surname>Lao</surname><given-names>V.</given-names></name><name><surname>Hwang</surname><given-names>M.</given-names></name><name><surname>Gardner</surname><given-names>S.</given-names></name><name><surname>Adney</surname><given-names>D.</given-names></name><name><surname>Munster</surname><given-names>V.</given-names></name></person-group><article-title>Middle East respiratory syndrome coronavirus intra-host populations are characterized by numerous high frequency variants</article-title><source>PLOS ONE</source><volume>11</volume><issue>1</issue><year>2016</year><fpage>e0146251</fpage><pub-id pub-id-type="pmid">26790002</pub-id></element-citation></ref><ref id="bib0165"><label>12</label><element-citation publication-type="journal" id="sbref0165"><person-group person-group-type="author"><name><surname>Assiri</surname><given-names>A.</given-names></name><name><surname>Abedi</surname><given-names>G.R.</given-names></name><name><surname>Saeed</surname><given-names>A.A.</given-names></name><name><surname>Abdalla</surname><given-names>M.A.</given-names></name><name><surname>Al-Masry</surname><given-names>M.</given-names></name><name><surname>Choudhry</surname><given-names>A.J.</given-names></name></person-group><article-title>Multifacility outbreak of Middle East respiratory syndrome in Taif, Saudi Arabia</article-title><source>Emerg Infect Dis</source><volume>22</volume><issue>1</issue><year>2016</year><fpage>32</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">26692003</pub-id></element-citation></ref><ref id="bib0170"><label>13</label><element-citation publication-type="journal" id="sbref0170"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>Y.</given-names></name><name><surname>Cheon</surname><given-names>S.</given-names></name><name><surname>Min</surname><given-names>C.K.</given-names></name><name><surname>Sohn</surname><given-names>K.M.</given-names></name><name><surname>Kang</surname><given-names>Y.J.</given-names></name><name><surname>Cha</surname><given-names>Y.J.</given-names></name></person-group><article-title>Spread of mutant Middle East respiratory syndrome coronavirus with reduced affinity to human CD26 during the South Korean outbreak</article-title><source>mBio</source><volume>7</volume><issue>2</issue><year>2016</year></element-citation></ref><ref id="bib0175"><label>14</label><element-citation publication-type="journal" id="sbref0175"><person-group person-group-type="author"><name><surname>Park</surname><given-names>W.B.</given-names></name><name><surname>Perera</surname><given-names>R.A.</given-names></name><name><surname>Choe</surname><given-names>P.G.</given-names></name><name><surname>Lau</surname><given-names>E.H.</given-names></name><name><surname>Choi</surname><given-names>S.J.</given-names></name><name><surname>Chun</surname><given-names>J.Y.</given-names></name></person-group><article-title>Kinetics of serologic responses to MERS coronavirus infection in humans, South Korea</article-title><source>Emerg Infect Dis</source><volume>21</volume><issue>12</issue><year>2015</year><fpage>2186</fpage><lpage>2189</lpage><pub-id pub-id-type="pmid">26583829</pub-id></element-citation></ref><ref id="bib0180"><label>15</label><element-citation publication-type="journal" id="sbref0180"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Chan</surname><given-names>K.H.</given-names></name><name><surname>Kang</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Luk</surname><given-names>H.</given-names></name><name><surname>Poon</surname><given-names>R.W.</given-names></name></person-group><article-title>A sensitive and specific antigen detection assay for Middle East respiratory syndrome coronavirus</article-title><source>Emerg Microbes Infect</source><volume>4</volume><issue>4</issue><year>2015</year><fpage>e26</fpage><pub-id pub-id-type="pmid">26421268</pub-id></element-citation></ref><ref id="bib0185"><label>16</label><element-citation publication-type="journal" id="sbref0185"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>B.</given-names></name><name><surname>Drosten</surname><given-names>C.</given-names></name><name><surname>Muller</surname><given-names>M.A.</given-names></name></person-group><article-title>Serological assays for emerging coronaviruses: challenges and pitfalls</article-title><source>Virus Res</source><volume>194</volume><year>2014</year><fpage>175</fpage><lpage>183</lpage><pub-id pub-id-type="pmid">24670324</pub-id></element-citation></ref><ref id="bib0190"><label>17</label><element-citation publication-type="journal" id="sbref0190"><person-group person-group-type="author"><name><surname>Perera</surname><given-names>R.A.</given-names></name><name><surname>Wang</surname><given-names>P.</given-names></name><name><surname>Gomaa</surname><given-names>M.R.</given-names></name><name><surname>El-Shesheny</surname><given-names>R.</given-names></name><name><surname>Kandeil</surname><given-names>A.</given-names></name><name><surname>Bagato</surname><given-names>O.</given-names></name></person-group><article-title>Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013</article-title><source>Euro Surveill</source><volume>18</volume><issue>36</issue><year>2013</year><comment>pii:20574</comment></element-citation></ref><ref id="bib0195"><label>18</label><element-citation publication-type="journal" id="sbref0195"><person-group person-group-type="author"><name><surname>Buchholz</surname><given-names>U.</given-names></name><name><surname>Muller</surname><given-names>M.A.</given-names></name><name><surname>Nitsche</surname><given-names>A.</given-names></name><name><surname>Sanewski</surname><given-names>A.</given-names></name><name><surname>Wevering</surname><given-names>N.</given-names></name><name><surname>Bauer-Balci</surname><given-names>T.</given-names></name></person-group><article-title>Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October–November 2012</article-title><source>Euro Surveill</source><volume>18</volume><issue>8</issue><year>2013</year></element-citation></ref><ref id="bib0200"><label>19</label><element-citation publication-type="journal" id="sbref0200"><person-group person-group-type="author"><name><surname>Corman</surname><given-names>V.M.</given-names></name><name><surname>Muller</surname><given-names>M.A.</given-names></name><name><surname>Costabel</surname><given-names>U.</given-names></name><name><surname>Timm</surname><given-names>J.</given-names></name><name><surname>Binger</surname><given-names>T.</given-names></name><name><surname>Meyer</surname><given-names>B.</given-names></name></person-group><article-title>Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections</article-title><source>Euro Surveill</source><volume>17</volume><issue>49</issue><year>2012</year></element-citation></ref><ref id="bib0205"><label>20</label><element-citation publication-type="journal" id="sbref0205"><person-group person-group-type="author"><name><surname>Muller</surname><given-names>M.A.</given-names></name><name><surname>Meyer</surname><given-names>B.</given-names></name><name><surname>Corman</surname><given-names>V.M.</given-names></name><name><surname>Al-Masri</surname><given-names>M.</given-names></name><name><surname>Turkestani</surname><given-names>A.</given-names></name><name><surname>Ritz</surname><given-names>D.</given-names></name></person-group><article-title>Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study</article-title><source>Lancet Infect Dis</source><volume>15</volume><issue>5</issue><year>2015</year><fpage>559</fpage><lpage>564</lpage><pub-id pub-id-type="pmid">25863564</pub-id></element-citation></ref><ref id="bib0210"><label>21</label><element-citation publication-type="journal" id="sbref0210"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.D.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>G.B.</given-names></name><name><surname>Dong</surname><given-names>X.Y.</given-names></name><name><surname>Yang</surname><given-names>X.A.</given-names></name><name><surname>Feng</surname><given-names>Z.R.</given-names></name></person-group><article-title>Detection of antibodies against SARS-CoV in serum from SARS-infected donors with ELISA and Western blot</article-title><source>Clin Immunol</source><volume>113</volume><issue>2</issue><year>2004</year><fpage>145</fpage><lpage>150</lpage><pub-id pub-id-type="pmid">15451470</pub-id></element-citation></ref></ref-list></back></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E39 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000E39 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé= PMC:7102781
|texte= MERS-CoV diagnosis: An update
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:27106390" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a MersV1
| This area was generated with Dilib version V0.6.33. |  |